65岁及以上1型糖尿病Medicare受益人中糖尿病并发症相关医疗费用
研究基于2006-2017年Medicare索赔数据库,纳入114,879例65岁及以上1型糖尿病受益人,随访3至10年,采用固定效应回归估算17种并发症及治疗程序的年均费用。费用最高的并发症为肾衰竭接受移植(发生年77,809美元,后续年13,556美元)、肾衰竭接受透析(56,469美元和41,429美元)及神经病变接受下肢截肢(40,698美元和7,380美元);充血性心力衰竭治疗占并发症总医疗费用的16%。
要点
- 肾衰竭接受移植发生年费用77,809美元,后续年13,556美元,为费用最高并发症。
- 肾衰竭接受透析发生年费用56,469美元,后续年41,429美元。
- 神经病变接受下肢截肢发生年费用40,698美元,后续年7,380美元。
核心结论
- 糖尿病并发症费用高昂且因并发症种类而异,结果可辅助用于预防或延缓65岁及以上1型糖尿病Medicare受益人并发症的治疗与干预的成本效果分析。
研究设计与样本
- 使用2006-2017年Medicare 100%索赔数据库,纳入参加按服务收费计划和Part D的受益人。
- 纳入114,879例1型糖尿病受益人,随访时间3至10年,从Medicare首次识别糖尿病年份(2006-2015)随访至死亡、退出计划覆盖或2017年12月31日。
- 采用固定效应回归估算并发症发生年及后续年份的费用,所有费用标准化为2017年美元。
主要发现
- 肾衰竭接受移植每人费用为发生年77,809美元、后续年13,556美元。
- 肾衰竭接受透析每人费用为发生年56,469美元、后续年41,429美元。
- 神经病变接受下肢截肢每人费用为发生年40,698美元、后续年7,380美元。
- 充血性心力衰竭治疗占糖尿病并发症总医疗费用的16%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate medical costs associated with 17 diabetes complications and treatment procedures among Medicare beneficiaries aged ≥65 years with type 1 diabetes. RESEARCH DESIGN AND METHODS: With use of the 2006-2017 100% Medicare claims database for beneficiaries enrolled in fee-for-service plans and Part D, we estimated the annual cost of 17 diabetes complications and treatment procedures. Type 1 diabetes and its complications and procedures were identified using ICD-9/ICD-10, procedure, and diagnosis-related group codes. Individuals with type 1 diabetes were followed from the year when their diabetes was initially identified in Medicare (2006-2015) until death, discontinuing plan coverage, or 31 December 2017. Fixed-effects regression was used to estimate costs in the complication occurrence year and subsequent years. The cost proportion of a complication was equal to the total cost of the complication, calculated by multiplying prevalence by the per-person cost divided by the total cost for all complications. All costs were standardized to 2017 U.S. dollars. RESULTS: Our study included 114,879 people with type 1 diabetes with lengths of follow-up from 3 to 10 years. The costliest complications per person were kidney failure treated by transplant ($77,809 in the occurrence year and $13,556 in subsequent years), kidney failure treated by dialysis ($56,469 and $41,429), and neuropathy treated by lower-extremity amputation ($40,698 and $7,380). Sixteen percent of the total medical cost for diabetes complications was for treating congestive heart failure. CONCLUSIONS: Costs of diabetes complications were large and varied by complications. Our results can assist in cost-effectiveness analysis of treatments and interventions for preventing or delaying diabetes complications in Medicare beneficiaries aged ≥65 years with type 1 diabetes.
引用
- Wang Y, Zhang P, Shao H, et al. Medical Costs Associated With Diabetes Complications in Medicare Beneficiaries Aged 65 Years or Older With Type 1 Diabetes. Diabetes Care. 2023. PMID: 36399714. doi:10.2337/dc21-2538
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。